SCHEMBL22366331

SCHEMBL22366331

COc1c(C)sc2ccccc12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
MAPK1 P28482 4/20 0.50
KDM4E B2RXH2 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MAPT P10636 6/20 0.46
NPC1 O15118 4/20 0.46
RAB9A P51151 4/20 0.46
HPGD P15428 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP3A4 P08684 2/20 0.46
CYP2C9 P11712 2/20 0.46
CYP2C19 P33261 2/20 0.46
GPR3 P46089 1/20 0.46
TUBB4A P04350 1/20 0.45
TUBB P07437 1/20 0.45
TUBA3C P0DPH7 1/20 0.45
TUBA1B P68363 1/20 0.45
TUBA4A P68366 1/20 0.45
TUBB4B P68371 1/20 0.45
TUBB3 Q13509 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10742442 0.80 MAPT (0.49) ALDH1A1MAPK1KDM4EMAPTHPGD
SCHEMBL7769015 0.79 ALDH1A1 (0.50) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL25383926 0.78 ALDH1A1 (0.48) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL30557573 0.78 ALDH1A1 (0.48) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL10421946 0.73 ALDH1A1 (0.43) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL6408883 0.73 CNR2 (0.44) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL8323182 0.73 TUBB4A (0.48) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL144440 0.73 GPR3 (0.55) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL10369586 0.72 CA2 (0.49) ALDH1A1MAPK1KDM4ESMN1; SMN2MAPT
SCHEMBL1098130 0.72 MCL1 (0.57) ALDH1A1MAPK1KDM4EMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111225907-B Process for preparing benzothien-2 yl boric acid/borate 拜耳制药股份公司 2023-05-26 CN disclosed
US-20220356194-A1 PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-11-10 US disclosed
US-11274110-B2 Process for preparing benzothiophen-2yl boronate BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2022-03-15 US disclosed
US-20200339606-A1 PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2020-10-29 US disclosed
EP-3700894-A1 PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE Bayer Pharma Aktiengesellschaft (DE) 2020-09-02 EP disclosed
CN-111225907-A Process for preparing benzothien-2-yl boronic acids/borates 拜耳制药股份公司 2020-06-02 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220356194-A1 PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE BPGM, BRCA1, BRAP ALDH1A1 1918/4885MAPK1 1021/4885KDM4E 1509/4885
US-20200339606-A1 PROCESS FOR PREPARING BENZOTHIOPHEN-2YL BORONATE BPGM, BRCA1, BRAP ALDH1A1 1918/4885MAPK1 1021/4885KDM4E 1509/4885
US-11274110-B2 Process for preparing benzothiophen-2yl boronate BPGM, BRCA1, BRAP ALDH1A1 1918/4885MAPK1 1021/4885KDM4E 1509/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.